Optos PLC

Optos PLC manufactures ultra-widefield retinal imaging systems for ophthalmology and optometry practices. The company specializes in optomap technology, which captures single-shot 200-degree ultra-widefield retinal images in a non-mydriatic format, enabling clinicians to visualize the peripheral retina without pupil dilation. Products include the optomap platform with multiple generations and the recently announced Silverstone RGB system, representing advances in retinal imaging technology. Optos provides comprehensive clinical decision support through optomap Recognizing Pathology, a searchable reference resource with case libraries organized by pathology type and imaging modality to assist healthcare professionals in identifying retinal pathology. The company operates a support portal offering self-help solutions and product guidance. Optos devices are widely deployed in eye care settings globally, serving ophthalmologists, optometrists, and eye care centers. The ultra-widefield imaging capability addresses a clinical need for comprehensive retinal assessment, particularly for detecting peripheral retinal disease, diabetic retinopathy, age-related macular degeneration, and other posterior segment pathologies. Products integrate with OCT (optical coherence tomography) scanning capabilities, providing multi-modal diagnostic imaging.